-
알렉스 보디와 남수단 공화국의 굼 도미니크 마티오크 대사, 베를린에서 부쿠레슈티 명예영사관 설치 가능성 논의
-
亞歷克斯・博迪與南蘇丹共和國大使古姆・多米尼克・馬蒂奧克在柏林商討於布加勒斯特設立名譽領事館的可能性
-
Russia strikes hit Kyiv as Germany's Merz visits
-
АЛЕКС БОДІ ТА ПОСОЛ РЕСПУБЛІКИ ПІВДЕННИЙ СУДАН ГУМ ДОМІНІК МАТІОК ОБГОВОРЮЮТЬ У БЕРЛІНІ МОЖЛИВІСТЬ ВІДКРИТТЯ ПОЧЕСНОГО КОНСУЛЬСТВА В БУХАРЕСТІ
-
South Korea captain 'deeply sorry' for gloating about military exemption
-
Germany's Merz in Kyiv for talks with Zelensky
-
Alcaraz through to Japan Open semis after Shapovalov injury
-
Asian Games set to close after records, rancour and rain
-
Chanel: unpicking one year of 'Blazymania'
-
Cry for help as French-Swiss lake dries up
-
Latvian pro-Europeans set for election win: partial results
-
Sabalenka swept out of China Open in third round
-
China swim sensation Yu Zidi, 13, says 'I'm no prodigy'
-
US urges 'restraint' as Ethiopia's Tigray crisis rocks region
-
Yu Zidi to Ohashi: Asian Games stars who can light up LA Olympics
-
Teens on target again as USA down Mexico 3-0
-
'Act before it's too late': Tokyo residents fight for more trees
-
World records prove Asian Games were a hit, says top official
-
'Disappointing' as South Korea flag mishap sees Games end on sour note
-
US prison chief who oversaw botched execution resigns
-
Pre-COP host Tuvalu at frontline of climate change
-
'Chaotic' Asian Games threaten Japan hopes of hosting Olympics again
-
Hungary's dwindling paprika producers battle to save signature spice
-
Finnish town braces for change from Google data centres
-
Cornell president vows review in wake of alleged student gang rape
-
What is fuelling French school protests?
-
Latvian partial election results suggest pro-European choice
-
Without lawyers, migrant children face deportation from the US
-
In Egypt's Sinai, Gazan builds school for children displaced by war
-
Three-peat seeking Dodgers open playoffs with a win, Rays hold off Yankees
-
Trump tariffs a mixed bag for US auto industry
-
Brazil votes in nail-biter polls closely watched by Trump
-
Yemen government forces say struck Houthi targets
-
'Just be you': Kim reveals Tiger text that inspired him to gold
-
Music links past, present for Pedro Pascal's cellist in 'Behemoth!'
-
Myanmar migrants returned to war-torn nation from Malaysia
-
ALEX BODI ȘI AMBASADORUL REPUBLICII SUDANUL DE SUD, GUM DOMINIC MATIOK, DISCUTĂ LA BERLIN DESPRE POSIBILITATEA ÎNFIINȚĂRII UNUI CONSULAT ONORIFIC LA BUCUREȘTI
-
ALEX BODI AND AMBASSADOR GUM DOMINIC MATIOK OF THE REPUBLIC OF SOUTH SUDAN MEET IN BERLIN TO DISCUSS THE POSSIBILITY OF AN HONORARY CONSULATE IN BUCHAREST
-
Dodgers step up World Series three-peat bid with 5-3 win over Braves
-
Lula, Bolsonaro wrap up campaigns ahead of Brazil's knife-edge vote
-
Spain break down Czechs as England outclass Croatia in Nations League
-
Toulouse edge Castres in Top 14 derby
-
Yamal on target as Spain hold off Czech Republic
-
Murakami homer propels White Sox to MLB playoff win over Guardians
-
Latvian exit polls suggest pro-European choice
-
Israel targets top Hamas leader in deadly Gaza strike on anniversary
-
Lula, Bolsonaro wrap up campaigns ahead of knife-edge election
-
Houthis say struck oil facility near Riyadh, as Saudis hit Sanaa
-
Tuchel hails 'complete' England after Croatia demolition
-
AI needs safety layers like nuclear plants: ex-OpenAI engineer
Japan firm probing 76 more deaths in supplement scare
Japanese health supplement maker Kobayashi Pharmaceutical said Friday it was probing 76 more deaths possibly linked to its tablets containing red yeast rice, meant to lower cholesterol.
It deepens a scandal that erupted earlier this year when the company said it was looking into five deaths potentially linked to the over-the-counter products after dozens of customers reported kidney problems.
Fermented with a mould culture, red yeast rice, or "beni koji", has been used in food, alcoholic drinks and folk medicines for centuries around East Asia.
"Even if the direct cause of hospitalisation or death was not kidney-related disease, it has become clear that there are a variety of cases, including cases in which beni koji-related products may have caused harm somehow and had some indirect impact," a Kobayashi statement said.
Of the five initial deaths under investigation, the company said it now knows one did not consume red yeast rice.
"We have received 1,656 inquiries from individuals who have sought medical attention, and have 76 cases under investigation over (a causal) connection to the deaths," in addition to the original four, it said.
On March 22, Kobayashi Pharmaceutical said it was recalling three kinds of tablets containing beni koji.
It later said it had detected a potentially toxic acid produced by the mould at one of its factories, and government officials inspected the firm's facilities.
Kobayashi Pharmaceutical is a household name in Japan, offering a wide range of health-related products, and the scandal has been top news in the country.
On Friday, Kobayashi said it would work to identify the exact cause and scope of the health damage -- including whether organs other than kidneys were harmed.
Top government spokesman Yoshimasa Hayashi said Friday that the health ministry had previously ordered the company to file a daily report on its probe, and demanded more details earlier this month after the number of deaths under investigation didn't change.
"But until today, it had not reported the specific number of cases under investigation, and it is extremely regrettable," Hayashi told reporters.
Kobayashi Pharmaceutical has said it also sold red yeast rice to around 50 other firms in Japan and two in Taiwan.
Taiwanese companies preventively recalled 154 products containing red yeast rice in the wake of the scare, the island's health authorities said earlier this year.
P.Santos--AMWN